Clinical Trial Results: PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea [Phase 2]

View source ↗

Summary

Phase 2 trial results for PDE4 inhibition in seborrheic dermatitis and papulopustular rosacea have been posted after termination of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea
• Seborrheic Dermatitis

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Seborrheic Dermatitis, Papulopustular Rosacea | Phase 2 | Status: TERMINATED | Results posted: 2026-08-14